Pharmacovigilance Market Growth, Demand and Challenges of the Key Industry Players 2024-2032

The global pharmacovigilance market size reached US$ 7.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 15.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.8% during 2024-2032.

More Info:- https://www.imarcgroup.com/pharmacovigilance-market

1. Global Pharmacovigilance Market Research and Forecast Report 2024-2032 Format: PDF+EXCEL © 2023 IMARC All Rights Reserved

2. About IMARC Group International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Highlight and Description According to the latest report by IMARC Group, titled  "Pharmacovigilance Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,"  the  global pharmacovigilance market size reached US$ 7.9 Billion in 2023. Pharmacovigilance (PV) is the pharmacological science of studying the detection, assessment, and prevention of unfavorable effects of pharmaceutical medicines. It plays a critical role in identifying previously unknown ADR (adverse drug reactions) and drug toxicity, determining changes in frequency or severity, and assessing the risks and benefits of drugs to determine required actions. It also assures the accuracy of communicated information to healthcare professionals and patients. As a result, PV is widely used to comprehend the effects of drugs on individuals across the globe. Request for a PDF sample of this report: https://www.imarcgroup.com/pharmacovigilance-market/requestsample

4. Report Description Global Pharmacovigilance Market Trends : The market is primarily driven by the rising prevalence of chronic diseases, such as diabetes, hypertension, oncological diseases, and cardiac disorders, resulting in the increasing consumption of drugs worldwide. In addition, the introduction of advanced platforms to ensure automated ADR reporting is contributing to market growth. Moreover, the sudden outbreak of coronavirus disease (COVID-19) and the consequent necessity for vaccination has also created several opportunities for the market players. This, coupled with the widespread adoption of new technologies in clinical research, such as the incorporation of virtual services in the clinical trial protocol, is augmenting the market growth. Besides this, leading companies are undertaking various initiatives to conduct clinical trials and generate awareness about the proper utilization of medicines, which is facilitating the market growth. Along with this, extensive research and development (R&D) activities conducted by major pharmaceutical and biotechnological companies to develop new drugs are providing a positive thrust to the market growth. Looking forward, IMARC Group expects the market value to reach US$ 15.9 Billion by 2032, exhibiting a CAGR of 7.8% during the forecast period (2024-2032). View Report TOC, Figures and Tables : https://www.imarcgroup.com/pharmacovigilance-market

5. Report Segmentation Breakup by Service Provider: In-house Contract Outsourcing   Breakup by Product Life Cycle: Pre-clinical Phase I Phase II Phase III Phase IV Breakup by Type: Spontaneous Reporting Intensified ADR Reporting Targeted Spontaneous Reporting Cohort Event Monitoring

6. Report Segmentation EHR Mining Breakup by Process Flow: Case Data Management Case Logging Case Data Analysis Medical Reviewing and Reporting Signal Detection Adverse Event Logging Adverse Event Analysis Adverse Event Review and Reporting Risk Management System Risk Evaluation System

7. Report Segmentation Risk Mitigation System Breakup by Therapeutic Area: Oncology Neurology Cardiology Respiratory Systems Others Breakup by End Use: Pharmaceuticals Companies Biotechnology Companies Medical Device Companies Others

8. Report Segmentation Breakup by Region: North America Asia-Pacific Europe Latin America Middle East and Africa

9. Competitive Landscape with Key Players Accenture plc ArisGlobal LLC BioClinica Inc. ( Cinven Partners LLP) Capgemini Cognizant International Business Machines Corporation ICON plc. IQVIA Inc. ITClinical Parexel International Corporation Wipro Limited

10. Key Questions Answered in the Report

11. Key Questions Answered in the Report

12. Table of Contents 1    Preface 2    Scope and Methodology     2.1    Objectives of the Study     2.2    Stakeholders     2.3    Data Sources         2.3.1    Primary Sources         2.3.2    Secondary Sources     2.4    Market Estimation         2.4.1    Bottom-Up Approach         2.4.2    Top-Down Approach     2.5    Forecasting Methodology 3    Executive Summary 4    Introduction     4.1    Overview     4.2    Key Industry Trends 5    Global Pharmacovigilance Market     5.1    Market Overview     5.2    Market Performance     5.3    Impact of COVID-19   5.4    Market Forecast 6     Market Breakup by Service Provider 6.1 In-house 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Contract Outsourcing 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Product Life Cycle 7.1 Pre-clinical 7.1.1 Market Trends 7.1.2 Market Forecast        

13. Table of Contents 7.2 Phase I 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Phase II 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Phase III 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Phase IV 7.5.1 Market Trends 7.5.2 Market Forecast 8 Market Breakup by Type 8.1 Spontaneous Reporting 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Intensified ADR Reporting 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Targeted Spontaneous Reporting 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Cohort Event Monitoring 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 EHR Mining 8.5.1 Market Trends 8.5.2 Market Forecast For more information, visit : https://www.imarcgroup.com/pharmacovigilance-market/toc

14. Partial List of Clients

15. Partial List of Clients

16. Disclaimer © 2024 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

17. Contact Us Visit us at : https://www.imarcgroup.com [phone] [email protected] Stay With Us: